Bevacizumab/ranibizumabConjunctiva haemorrhage and lens injury: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1958卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39775-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[1] Bevacizumab/erlotinibRash and intratumoural haemorrhage: 4 case reports
[J]. Reactions Weekly, 2013, 1451 (1) : 11 - 11
[2] Bevacizumab/dalteparin sodiumIntracranial haemorrhage: 7 case reports
[J]. Reactions Weekly, 2012, 1391 (1) : 13 - 13
[3] Bevacizumab/ranibizumabSubmacular haemorrhage treated with alteplase in elderly patients: 3 case reports
[J]. Reactions Weekly, 2011, 1360 (1) : 12 - 12
[4] Bevacizumab/sunitinib/vandetanibIschaemic stroke and intracranial haemorrhage: 22 case reports
[J]. Reactions Weekly, 2017, 1638 (1) : 52 - 52
[5] AlteplaseIntracranial haemorrhage: 3 case reports
[J]. Reactions Weekly, 2016, 1625 (1) : 22 - 22
[6] AlteplaseIntracranial haemorrhage: 3 case reports
[J]. Reactions Weekly, 2010, 1310 (1) : 9 - 9
[7] AspirinIntracerebral haemorrhage: 3 case reports
[J]. Reactions Weekly, 2021, 1866 (1) : 71 - 71
[8] WarfarinIntracranial haemorrhage: 3 case reports
[J]. Reactions Weekly, 2021, 1883 (1) : 363 - 363
[9] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
[J]. Reactions Weekly, 2015, 1576 (1) : 61 - 61
[10] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
[J]. Reactions Weekly, 2013, 1444 (1) : 11 - 11

← 1 2 3 4 5 →